Ibutilide and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Ibutilide
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both buprenorphine (a pain and addiction medicine) and ibutilide (a medicine used to correct an irregular heartbeat) can affect the heart's electrical timing, something doctors call the QT interval. When two medicines that do this are used together, that effect can add up and, in rare cases, lead to a dangerous heart rhythm.
The good news is that this concern is based on theory rather than lots of real-world reports, and your care team knows how to watch for it. Please don't stop either medicine on your own. Just talk with your doctor or pharmacist, especially if you have a history of heart problems, low potassium, or low magnesium.
Effect: Additive QT interval prolongation, raising the theoretical risk of torsades de pointes. Neither agent is metabolically dependent on the other; this is a pharmacodynamic (additive), not pharmacokinetic, interaction.
- Direction: Both drugs independently prolong QT; combined effect is additive.
- Magnitude/onset: Not quantified; onset unspecified.
- Evidence: Theoretical; combined risk not established.
- Management: Ibutilide is a known potent QT-prolonging antiarrhythmic. Avoid concomitant use where possible. If unavoidable, correct hypokalemia/hypomagnesemia, obtain baseline and follow-up ECGs, and telemetry monitor around ibutilide administration. Assess for bradycardia, CHF, recent AF cardioversion, digitalis use, and congenital/subclinical long-QT.
What happens
An increased risk of QT interval prolongation
Interaction Deep Dive
Buprenorphine should not be used together with medications capable of extending the QT interval 342. It remains unclear what risk arises when buprenorphine is paired with other agents that cause QT prolongation. When prescribing buprenorphine to individuals who carry risk factors, including hypokalemia, bradycardia, a recent conversion from atrial fibrillation, congestive heart failure, treatment with digitalis, baseline QT prolongation, subclinical long-QT syndrome, or severe hypomagnesemia, clinicians should take these points into account in their decisions 1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Because both medicines can lengthen the heart's QT interval, your care team's general approach is:
- Avoiding the combination when possible. Ibutilide is usually given in a monitored hospital setting, and your team will weigh whether both are truly needed.
- Closer monitoring. Expect heart tracing (ECG) checks and monitoring of potassium and magnesium levels, since low levels raise the risk.
Keep taking both exactly as prescribed unless your doctor tells you otherwise. Tell your care team about any history of heart rhythm problems, heart failure, slow heartbeat, or recent treatment for atrial fibrillation, and report fainting, dizziness, or palpitations right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Common questions
Can I take Ibutilide and Buprenorphine together?
Buprenorphine and ibutilide can each prolong the QT interval, so combining them may add up and raise the risk of a serious heart rhythm; your care team will typically avoid this pairing or monitor your ECG and electrolytes closely. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Ibutilide and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Ibutilide and Buprenorphine interaction managed?
Because both medicines can lengthen the heart's QT interval, your care team's general approach is: Avoiding the combination when possible. Ibutilide is usually given in a monitored hospital setting, and your team will weigh whether both are truly needed. Closer monitoring. Expect heart tracing (ECG) checks and monitoring of potassium and magnesium levels, since low levels raise the risk. Keep taki… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Ibutilide or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (4)
- Product Information: BRIXADI(TM) subcutaneous extended-release injection, buprenorphine subcutaneous extended-release injection. Braeburn Inc (per FDA), Plymouth Meeting, PA, 2023. DailyMed
- Product Information: BUTRANS(R) transdermal system patch, buprenorphine transdermal system patch. Purdue Pharma L.P. (per FDA), Stamford, CT, 2016. DailyMed
- Product Information: BELBUCA(TM) buccal film, buprenorphine buccal film. Endo Pharmaceuticals Inc. (per FDA), Malvern, PA, 2016.
- Product Information: BUPRENEX(R) intravenous injection, intramuscular injection, buprenorphine HCl intravenous injection, intramuscular injection. Indivior Inc. (per DailyMed), Richmond, VA, 2016. DailyMed
Keep reading about Buprenorphine
Keep reading about Ibutilide
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist